搜索结果
疾病ID:TCMBANKDI013745
疾病名:stage, non-small cell lung cancer
MeSH_Name:Neoplasms; Respiratory Tract Diseases
HPO_Name:-
UMLS_Name:Neoplastic Process
DO_Name:-
疾病类型:disease
DisGeNET_Link:C0280217
MeSH_Link:C04; C08
HPO_Link:-
UMLS_Link:T191
DO_Link:-
HERB_ID:-
疾病对应的植物
| ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
|---|
疾病对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
疾病对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE013691 | CXCL5 | ENA-78; SCYB5 | C-X-C motif chemokine ligand 5 |
| TCMBANKGE005752 | SLC5A10 | SGLT-5; SGLT5 | solute carrier family 5 member 10 |
| TCMBANKGE000799 | AGER | RAGE; SCARJ1 | advanced glycosylation end-product specific receptor |
| TCMBANKGE001033 | FGFR1 | BFGFR; CD331; CEK; ECCL; FGFBR; FGFR-1; FLG; FLT-2; FLT2; HBGFR; HH2; HRTFDS; KAL2; N-SAM; OGD; bFGF-R-1 | fibroblast growth factor receptor 1 |
| TCMBANKGE014946 | ALK | CD246; NBLST3 | ALK receptor tyrosine kinase |
| TCMBANKGE000567 | CDKN2A | ARF; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS-1; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4; P16INK4A; P19; P19ARF; TP16 | cyclin dependent kinase inhibitor 2A |
| TCMBANKGE000955 | ABCC2 | ABC30; CMOAT; DJS; MRP2; cMRP | ATP binding cassette subfamily C member 2 |
| TCMBANKGE001103 | MDM2 | ACTFS; HDMX; LSKB; hdm2 | MDM2 proto-oncogene |
| TCMBANKGE000818 | ROS1 | MCF3; ROS; c-ros-1 | ROS proto-oncogene 1, receptor tyrosine kinase |
| TCMBANKGE004194 | PC | PCB | pyruvate carboxylase |
| TCMBANKGE012524 | CHKA | CHK; CK; CKI; EK | choline kinase alpha |
| TCMBANKGE000928 | RRM1 | R1; RIR1; RR1 | ribonucleotide reductase catalytic subunit M1 |
| TCMBANKGE012197 | PTGDR | AS1; ASRT1; DP; DP1; PTGDR1 | prostaglandin D2 receptor |
| TCMBANKGE000047 | AKT1 | AKT; CWS6; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA | AKT serine/threonine kinase 1 |
| TCMBANKGE000925 | PCNA | ATLD2 | proliferating cell nuclear antigen |
| TCMBANKGE002613 | KRT19 | CK19; K19; K1CS | keratin 19 |
| TCMBANKGE010864 | SFTPA1 | COLEC4; PSAP; PSP-A; PSPA; SFTP1; SFTPA1B; SP-A; SP-A1; SP-A1 beta; SP-A1 delta; SP-A1 epsilon; SP-A1 gamma; SPA; SPA1 | surfactant protein A1 |
| TCMBANKGE000201 | ESR1 | ER; ESR; ESRA; ESTRR; Era; NR3A1 | estrogen receptor 1 |
| TCMBANKGE000196 | FAS | ALPS1A; APO-1; APT1; CD95; FAS1; FASTM; TNFRSF6 | Fas cell surface death receptor |
| TCMBANKGE007905 | KRT81 | HB1; Hb-1; KRTHB1; MLN137; ghHkb1; hHAKB2-1 | keratin 81 |
| TCMBANKGE000986 | ERBB2 | CD340; HER-2; HER-2/neu; HER2; MLN 19; NEU; NGL; TKR1 | erb-b2 receptor tyrosine kinase 2 |
| TCMBANKGE006461 | CUX1 | CASP; CDP; CDP/Cut; CDP1; COY1; CUTL1; CUX; Clox; Cux/CDP; GDDI; GOLIM6; Nbla10317; p100; p110; p200; p75 | cut like homeobox 1 |
| TCMBANKGE001257 | RET | CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET-ELE1 | ret proto-oncogene |
| TCMBANKGE000611 | CSF2 | CSF; GMCSF | colony stimulating factor 2 |
| TCMBANKGE001107 | NOS3 | ECNOS; eNOS | nitric oxide synthase 3 |
| TCMBANKGE003115 | USP22 | USP3L | ubiquitin specific peptidase 22 |
| TCMBANKGE001532 | ERCC1 | COFS4; RAD10; UV20 | ERCC excision repair 1, endonuclease non-catalytic subunit |
| TCMBANKGE005575 | GTF2B | TF2B; TFIIB | general transcription factor IIB |
| TCMBANKGE006806 | FUT4 | CD15; ELFT; FCT3A; FUC-TIV; FUTIV; LeX; SSEA-1 | fucosyltransferase 4 |
| TCMBANKGE001161 | IL2 | IL-2; TCGF; lymphokine | interleukin 2 |
| TCMBANKGE004813 | NKX2-1 | BCH; BHC; NK-2; NKX2.1; NKX2A; NMTC1; T/EBP; TEBP; TITF1; TTF-1; TTF1 | NK2 homeobox 1 |
| TCMBANKGE000792 | FASLG | ALPS1B; APT1LG1; APTL; CD178; CD95-L; CD95L; FASL; TNFSF6; TNLG1A | Fas ligand |
| TCMBANKGE000793 | ALDH1A1 | ALDC; ALDH-E1; ALDH1; ALDH11; HEL-9; HEL-S-53e; HEL12; PUMB1; RALDH1 | aldehyde dehydrogenase 1 family member A1 |
| TCMBANKGE000898 | MYC | MRTL; MYCC; bHLHe39; c-Myc | MYC proto-oncogene, bHLH transcription factor |
| TCMBANKGE002800 | TRIM28 | KAP1; PPP1R157; RNF96; TF1B; TIF1B | tripartite motif containing 28 |
| TCMBANKGE007517 | S100A13 | - | S100 calcium binding protein A13 |
| TCMBANKGE008385 | MAP3K8 | AURA2; COT; EST; ESTF; MEKK8; TPL2; Tpl-2; c-COT | mitogen-activated protein kinase kinase kinase 8 |
| TCMBANKGE001097 | HIF1A | HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; MOP1; PASD8; bHLHe78 | hypoxia inducible factor 1 subunit alpha |
| TCMBANKGE001178 | STAT3 | ADMIO; ADMIO1; APRF; HIES | signal transducer and activator of transcription 3 |
| TCMBANKGE002410 | PITX2 | ARP1; ASGD4; Brx1; IDG2; IGDS; IGDS2; IHG2; IRID2; Otlx2; PTX2; RGS; RIEG; RIEG1; RS | paired like homeodomain 2 |
| TCMBANKGE006666 | INTS6 | DBI-1; DDX26; DDX26A; DICE1; HDB; INT6; Notchl2 | integrator complex subunit 6 |
| TCMBANKGE000971 | MIR20A | C13orf25; MIR17HG; MIR20; MIRH1; MIRHG1; MIRN20; MIRN20A; hsa-mir-20; hsa-mir-20a; miR-20; miRNA20A; mir-20a | microRNA 20a |
| TCMBANKGE008107 | S100A1 | S100; S100-alpha; S100A | S100 calcium binding protein A1 |
| TCMBANKGE000280 | VIM | - | vimentin |
| TCMBANKGE000587 | ITGAM | CD11B; CR3A; MAC-1; MAC1A; MO1A; SLEB6 | integrin subunit alpha M |
| TCMBANKGE000940 | TERT | CMM9; DKCA2; DKCB4; EST2; PFBMFT1; TCS1; TP2; TRT; hEST2; hTRT | telomerase reverse transcriptase |
| TCMBANKGE001748 | GLDC | GCE; GCSP; HYGN1 | glycine decarboxylase |
| TCMBANKGE001158 | LEP | LEPD; OB; OBS | leptin |
| TCMBANKGE000277 | CD33 | SIGLEC-3; SIGLEC3; p67 | CD33 molecule |
| TCMBANKGE001739 | THBS2 | TSP2 | thrombospondin 2 |
| TCMBANKGE000935 | S100B | NEF; S100; S100-B; S100beta | S100 calcium binding protein B |
| TCMBANKGE012145 | CDO1 | CDO-I | cysteine dioxygenase type 1 |
| TCMBANKGE001160 | CD274 | B7-H; B7H1; PD-L1; PDCD1L1; PDCD1LG1; PDL1; hPD-L1 | CD274 molecule |
| TCMBANKGE000071 | BTG2 | APRO1; PC3; TIS21 | BTG anti-proliferation factor 2 |
| TCMBANKGE000074 | MIR221 | MIRN221; miRNA221; mir-221 | microRNA 221 |
| TCMBANKGE002949 | ENO2 | HEL-S-279; NSE | enolase 2 |
| TCMBANKGE009552 | SFTPA2 | COLEC5; PSAP; PSP-A; PSPA; SFTP1; SFTPA2B; SP-2A; SP-A; SPA2; SPAII | surfactant protein A2 |
| TCMBANKGE014470 | COL4A3 | ATS2; ATS3 | collagen type IV alpha 3 chain |
| TCMBANKGE009874 | CDKN2B | CDK4I; INK4B; MTS2; P15; TP15; p15INK4b | cyclin dependent kinase inhibitor 2B |
| TCMBANKGE000659 | TLR3 | CD283; IIAE2 | toll like receptor 3 |
| TCMBANKGE001144 | CD14 | - | CD14 molecule |
| TCMBANKGE001021 | MUC1 | ADMCKD; ADMCKD1; CA 15-3; CD227; EMA; H23AG; KL-6; MAM6; MCD; MCKD; MCKD1; MUC-1; MUC-1/SEC; MUC-1/X; MUC1/ZD; PEM; PEMT; PUM | mucin 1, cell surface associated |
| TCMBANKGE004740 | CRTAP | CASP; LEPREL3; OI7; P3H5 | cartilage associated protein |
| TCMBANKGE001056 | KRAS | C-K-RAS; C-K-RAS; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; K-Ras; K-Ras 2; KI-RAS; KRAS1; KRAS2; NS; NS3; OES; RALD; RASK2; c-Ki-ras; c-Ki-ras2 | KRAS proto-oncogene, GTPase |
| TCMBANKGE008754 | H3P10 | p16 | H3 histone pseudogene 10 |
| TCMBANKGE001201 | MAPK3 | ERK-1; ERK1; ERT2; HS44KDAP; HUMKER1A; P44ERK1; P44MAPK; PRKM3; p44-ERK1; p44-MAPK | mitogen-activated protein kinase 3 |
| TCMBANKGE001045 | CCND1 | BCL1; D11S287E; PRAD1; U21B31 | cyclin D1 |
| TCMBANKGE000735 | VDAC1 | PORIN; VDAC-1 | voltage dependent anion channel 1 |
| TCMBANKGE007372 | S100A2 | CAN19; S100L | S100 calcium binding protein A2 |
| TCMBANKGE010816 | CYTIP | B3-1; CASP; CYBR; CYTHIP; HE; PSCDBP | cytohesin 1 interacting protein |
| TCMBANKGE014315 | DRG2 | - | developmentally regulated GTP binding protein 2 |
| TCMBANKGE012224 | VDR | NR1I1; PPP1R163 | vitamin D receptor |
| TCMBANKGE004560 | CMTM6 | CKLFSF6; PRO2219 | CKLF like MARVEL transmembrane domain containing 6 |
| TCMBANKGE011990 | CEACAM5 | CD66e; CEA | CEA cell adhesion molecule 5 |
| TCMBANKGE004906 | EPHB6 | HEP | EPH receptor B6 |
| TCMBANKGE000868 | NFATC1 | NF-ATC; NF-ATc1.2; NFAT2; NFATc | nuclear factor of activated T cells 1 |
| TCMBANKGE008116 | LILRB1 | CD85J; ILT-2; ILT2; LIR-1; LIR1; MIR-7; MIR7; PIR-B; PIRB | leukocyte immunoglobulin like receptor B1 |
| TCMBANKGE011186 | CHRNA3 | BAIPRCK; LNCR2; NACHRA3; PAOD2 | cholinergic receptor nicotinic alpha 3 subunit |
滇IICP备16009434号-1 |
Dai SX Lab